These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 2305221)
1. [Evaluation of tolerance, efficacy and safety of 3-year simvastatin use in the treatment of primary hypercholesterolemia]. Darioli R; Bovet P; Brunner HR; Bercher L Schweiz Med Wochenschr; 1990 Jan; 120(4):85-91. PubMed ID: 2305221 [TBL] [Abstract][Full Text] [Related]
2. [Effects and side effects of a 1-year treatment of primary hypercholesterolemia with simvastatin]. Brocard JJ; Keller U; Oberhänsli A; Riesen WF Schweiz Med Wochenschr; 1991 Jun; 121(26):977-83. PubMed ID: 1862314 [TBL] [Abstract][Full Text] [Related]
3. [Effects of simvastatin on atherogenic blood lipid pattern]. Alessandri C; Peverini F; Basili S; Barsi R; Paradiso M; Marotta P; Censi C; Cordova C; Balsano F Recenti Prog Med; 1991 Apr; 82(4):225-9. PubMed ID: 1857842 [TBL] [Abstract][Full Text] [Related]
4. [Simvastatin in the treatment of hypercholesterolemia]. Cigala O; Pancallo MT; Della Valle M; Marasco A; Malarbi AL Clin Ter; 1991 Jun; 137(5):333-7. PubMed ID: 1832606 [TBL] [Abstract][Full Text] [Related]
5. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences]. Geisel J; Oette K; Burrichter H Fortschr Med; 1990 Feb; 108(4):71-2, 75-6. PubMed ID: 2312032 [TBL] [Abstract][Full Text] [Related]
6. Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial. Leclercq V; Harvengt C Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):76-81. PubMed ID: 2921098 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia. Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392 [TBL] [Abstract][Full Text] [Related]
8. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia]. Riesen WF; Keller U; Del Bufalo A; Reutter FW; Baur HR; Golay A; Bertel O; Kummer H; Kistler H; Ammann F Schweiz Med Wochenschr; 1989 Dec; 119(48):1719-23. PubMed ID: 2694363 [TBL] [Abstract][Full Text] [Related]
9. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide]. Berioli S; Bentivoglio M; Conti R; Osanna RA; Savino K; Zollino L; Corea L Cardiologia; 1990 Apr; 35(4):335-40. PubMed ID: 2245435 [TBL] [Abstract][Full Text] [Related]
10. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia. Pappu AS; Bacon SP; Illingworth DR J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170 [TBL] [Abstract][Full Text] [Related]
11. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study]. Ghizzoni G; Rusconi C; Faggiano P; Sabatini T; Oneglia C; Gardini A Minerva Cardioangiol; 1993 Mar; 41(3):105-9. PubMed ID: 8510811 [TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of simvastatin, a new cholesterol-lowering drug]. Mol MJ; Stuyt PM; Stalenhoef AF Ned Tijdschr Geneeskd; 1989 Feb; 133(7):362-6. PubMed ID: 2927555 [TBL] [Abstract][Full Text] [Related]
13. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease. French JK; White HD; Greaves SC N Z Med J; 1990 Feb; 103(883):41-3. PubMed ID: 2304688 [TBL] [Abstract][Full Text] [Related]
14. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I. Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of hypercholesterolemic patients of different age with simvastatin: 1-year study]. Pernigotti L; Bo M; Poli L; Zanocchi M; Fiandra U; Pedrazzini V; Fabris F Recenti Prog Med; 1991 Mar; 82(3):155-62. PubMed ID: 2047557 [TBL] [Abstract][Full Text] [Related]
16. [Effects of simvastatin on plasma levels of lipids, lipoproteins and apolipoproteins in primary hypercholesterolemia]. Caruzzo C; Uslenghi E; Varbella F; Caruzzo E; Marcolongo M; Brusca A Minerva Cardioangiol; 1989 Dec; 37(12):509-15. PubMed ID: 2695857 [TBL] [Abstract][Full Text] [Related]
17. [Comparative effects of policosanol and two HMG-CoA reductase inhibitors on type II hypercholesterolemia]. Prat H; Román O; Pino E Rev Med Chil; 1999 Mar; 127(3):286-94. PubMed ID: 10436712 [TBL] [Abstract][Full Text] [Related]
18. [Simvastatin in the treatment of familial hypercholesterolemia]. Ceska R; Sobra J; Procházková R; Kvasilová M Cas Lek Cesk; 1995 May; 134(10):310-3. PubMed ID: 7788650 [TBL] [Abstract][Full Text] [Related]
19. [Simvastatin (MK-733), a new HMG-CoA reductase inhibitor, in the treatment of hypercholesterolemia in elderly patients with atherosclerosis]. Giannini SD; de Góes JM; Dereviack BE; Machado C; Forti N; Diament J Arq Bras Cardiol; 1990 Jun; 54(6):407-14. PubMed ID: 2288531 [TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia. Farnier M; Bonnefous F; Debbas N; Irvine A Arch Intern Med; 1994 Feb; 154(4):441-9. PubMed ID: 8117177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]